Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Soldan, M Mateo Paz
NCT05357833: Novel Imaging Markers in SPMS	Completed	1	11	US	Ferumoxytol infusion, Feraheme, Gadoteridol, ProHance, gadolinium-based MRI contrast agent, MRI Brain and Cervical Spine	University of Utah	Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis	09/23	09/23
Francis, Trieste
CELLO, NCT04877457: Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.	Terminated	4	3	US	Ocrelizumab, Placebo	Yale University, Genentech, Inc.	Radiologically Isolated Syndrome, Multiple Sclerosis	06/23	06/23
NCT05357833: Novel Imaging Markers in SPMS	Completed	1	11	US	Ferumoxytol infusion, Feraheme, Gadoteridol, ProHance, gadolinium-based MRI contrast agent, MRI Brain and Cervical Spine	University of Utah	Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis	09/23	09/23